标题
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
作者
关键词
-
出版物
Nature Reviews Urology
Volume 9, Issue 1, Pages 41-51
出版商
Springer Nature
发表日期
2011-12-13
DOI
10.1038/nrurol.2011.193
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Long-term response in advanced bladder cancer involving the use of temsirolimus and vinflunine after platin resistance
- (2011) Holger Gerullis et al. ANTI-CANCER DRUGS
- Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75
- (2011) Noah M. Hahn et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiplexed Methylation Profiles of Tumor Suppressor Genes in Bladder Cancer
- (2011) Maria José Cabello et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment
- (2011) Steven Christopher Smith et al. LANCET ONCOLOGY
- Multicolor FISH (UroVysion) Facilitates Follow-up of Patients With High-Grade Urothelial Carcinoma of the Bladder
- (2010) Hans-Martin Fritsche et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications
- (2010) Satish K. Tickoo et al. BJU INTERNATIONAL
- Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder
- (2010) Christian Bolenz et al. BJU INTERNATIONAL
- Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy
- (2010) Luciana Schultz et al. CANCER
- Transitional research in bladder cancer: From molecular pathogenesis to useful tissue biomarkers
- (2010) Christian Bolenz et al. CANCER BIOLOGY & THERAPY
- Preclinical evaluation of a gene therapy treatment for transitional cell carcinoma
- (2010) X Zhang et al. CANCER GENE THERAPY
- Combined Gene Expression and Genomic Profiling Define Two Intrinsic Molecular Subtypes of Urothelial Carcinoma and Gene Signatures for Molecular Grading and Outcome
- (2010) David Lindgren et al. CANCER RESEARCH
- Fibroblast Growth Factor Receptor 3 Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle-Invasive Bladder Cancer
- (2010) T. C. M. Zuiverloon et al. CLINICAL CANCER RESEARCH
- Gene Expression Signature in Urine for Diagnosing and Assessing Aggressiveness of Bladder Urothelial Carcinoma
- (2010) L. Mengual et al. CLINICAL CANCER RESEARCH
- Hypermethylation of CpG Islands and Shores around Specific MicroRNAs and Mirtrons Is Associated with the Phenotype and Presence of Bladder Cancer
- (2010) Ewa Dudziec et al. CLINICAL CANCER RESEARCH
- Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways
- (2010) Hervé Wallerand et al. CURRENT OPINION IN UROLOGY
- Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer
- (2010) Bas W.G. van Rhijn et al. EUROPEAN UROLOGY
- The origins of urothelial carcinoma
- (2010) Liang Cheng et al. Expert Review of Anticancer Therapy
- Novel strategies for treating relapsed/refractory urothelial carcinoma
- (2010) Gopa Iyer et al. Expert Review of Anticancer Therapy
- Bladder cancer: translating molecular genetic insights into clinical practice
- (2010) Liang Cheng et al. HUMAN PATHOLOGY
- Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of FGFR3 mutations and hypermethylation events
- (2010) Reza R. Serizawa et al. INTERNATIONAL JOURNAL OF CANCER
- Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer
- (2010) Erik D. Wiklund et al. INTERNATIONAL JOURNAL OF CANCER
- A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression
- (2010) Céline Vallot et al. JNCI-Journal of the National Cancer Institute
- Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway
- (2010) Christina Barbara Ching et al. LABORATORY INVESTIGATION
- A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
- (2010) Nathaniel Rothman et al. NATURE GENETICS
- Molecular screening for bladder cancer: progress and potential
- (2010) Anirban P. Mitra et al. Nature Reviews Urology
- FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
- (2010) Lucie C. Kompier et al. PLoS One
- Die Target-Therapie urologischer Tumoren
- (2010) M.W. Kramer et al. UROLOGE
- A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102
- (2009) G. K. Philips et al. ANNALS OF ONCOLOGY
- A multicolour fluorescencein situhybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy
- (2009) Jared Whitson et al. BJU INTERNATIONAL
- p53 expression in patients with advanced urothelial cancer of the urinary bladder
- (2009) Shahrokh F. Shariat et al. BJU INTERNATIONAL
- A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma
- (2009) Christian Wülfing et al. CANCER
- Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
- (2009) J. W.F. Catto et al. CANCER RESEARCH
- Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer
- (2009) Makito Miyake et al. CANCER SCIENCE
- Genome-wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage
- (2009) Naotaka Nishiyama et al. CANCER SCIENCE
- EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis
- (2009) R. A. Mason et al. CARCINOGENESIS
- Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer
- (2009) F. M. Platt et al. CLINICAL CANCER RESEARCH
- Predicting Recurrence and Progression of Noninvasive Papillary Bladder Cancer at Initial Presentation Based on Quantitative Gene Expression Profiles
- (2009) Marc Birkhahn et al. EUROPEAN UROLOGY
- 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology
- (2009) Shigeto Kawauchi et al. HUMAN PATHOLOGY
- The prognostic value of cytology and fluorescencein situhybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy
- (2009) Spasenija Savic et al. INTERNATIONAL JOURNAL OF CANCER
- Role of Polysomy 17 in Transitional Cell Carcinoma of the Bladder: Immunohistochemical Study of HER2/neu Expression and FISH Analysis of c-erbB-2 Gene and Chromosome 17
- (2009) Sara Simonetti et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Generation of a Concise Gene Panel for Outcome Prediction in Urinary Bladder Cancer
- (2009) Anirban P. Mitra et al. JOURNAL OF CLINICAL ONCOLOGY
- Multi-Institutional Validation of the Predictive Value of Ki-67 Labeling Index in Patients With Urinary Bladder Cancer
- (2009) V. Margulis et al. JNCI-Journal of the National Cancer Institute
- Predictive Value of Combined Immunohistochemical Markers in Patients With pT1 Urothelial Carcinoma at Radical Cystectomy
- (2009) Shahrokh F. Shariat et al. JOURNAL OF UROLOGY
- Prospective Validation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder
- (2009) Bruce J. Schlomer et al. JOURNAL OF UROLOGY
- Non-invasive papillary urothelial neoplasms: The 2004 WHO/ISUP classification system
- (2009) Hiroshi Miyamoto et al. PATHOLOGY INTERNATIONAL
- Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine
- (2009) Hui-Hui Lin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Quantitative methylation analysis of BCL2, hTERT, and DAPK promoters in urine sediment for the detection of non-muscle-invasive urothelial carcinoma of the bladder: A prospective, two-center validation study
- (2009) Serena Vinci et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Targeting angiogenesis in bladder cancer
- (2009) Aymen A. Elfiky et al. Current Oncology Reports
- HER2Overexpression and Amplification in Urothelial Carcinoma of the Bladder Is Associated WithMYCCoamplification in a Subset of Cases
- (2008) Donna E. Hansel et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Molecular Pathogenesis and Diagnostics of Bladder Cancer
- (2008) Anirban P. Mitra et al. Annual Review of Pathology-Mechanisms of Disease
- EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology
- (2008) SEBASTIAN LEIBL et al. APMIS
- Promoter analysis of epigenetically controlled genes in bladder cancer
- (2008) Srinivas Veerla et al. GENES CHROMOSOMES & CANCER
- p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ
- (2008) Ming Yin et al. HUMAN PATHOLOGY
- Les thérapeutiques ciblées du cancer de vessie localement avancé et/ou métastatique
- (2008) H. Wallerand et al. PROGRES EN UROLOGIE
- Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy
- (2007) Shahrokh F. Shariat et al. CANCER
- Hypoxia-inducible factor-1 expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma
- (2007) C-Y Chai et al. JOURNAL OF CLINICAL PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now